Therefore, reducing the specific inhibition of MMPs by modulating the Nrf2/HO-1 signaling pathway may have positive significance for the treatment of IBD-induced intestinal fibrosis. This evidence concerns the gene NFE2L2 and inflammatory bowel disease.